Enveric Biosciences

About:

Enveric Biosciences is a patient-first biotechnology company developing rigorously tested, novel cannabinoid medicines.

Website: https://www.enveric.com/

Description:

Enveric Biosciences is a patient-centric biotechnology company endeavoring to enhance the lives of those who are adversely affected by the side effects of cancer treatments. Enveric Biosciences has set out with the goal of rigorously testing natural compounds, starting with cannabinoids, to provide patients and clinicians with novel prescription medicines to serve these unmet medical needs.

Total Funding Amount:

$42.6M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Naples, Florida, United States

Founded Date:

1994-01-01

Contact Email:

info(AT)enveric.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2023-12-29

IPO Status:

Public

Industries:

© 2025 bioDAO.ai